Effect of Memantine on Radiotherapy-related Cognitive Impairment

NCT03342443 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Cognitive Impairment

Interventions

DRUG: Memantine
DRUG: Placebo

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University